| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1029001103 |
| P356 | DOI | 10.1038/NRRHEUM.2015.40 |
| P698 | PubMed publication ID | 25825281 |
| P50 | author | Sarah Skeoch | Q57783358 |
| Ian Bruce | Q30348366 | ||
| P2093 | author name string | Ian N Bruce | |
| Sarah Skeoch | |||
| P2860 | cites work | Genome-wide mapping of susceptibility to coronary artery disease identifies a novel replicated locus on chromosome 17 | Q21145265 |
| Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome. | Q53488856 | ||
| Proinflammatory HLA-DRB1*01-haplotype predisposes to ST-elevation myocardial infarction. | Q53669495 | ||
| Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. | Q54301756 | ||
| A tale of two diseases: atherosclerosis and rheumatoid arthritis. | Q54448410 | ||
| Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug–induced clinical remission: Evidence from an imaging study may explain structural progression | Q56420367 | ||
| Predictors of response to anti-TNF- therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register | Q57751361 | ||
| Baseline levels of c-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis : A ten-year followup study of a primary care-based inception cohort | Q57804967 | ||
| Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study | Q58160099 | ||
| Arterial hypertension assessed "out-of-office" in a contemporary cohort of rheumatoid arthritis patients free of cardiovascular disease is characterized by high prevalence, low awareness, poor control and increased vascular damage-associated "white c | Q59303860 | ||
| Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis | Q61628540 | ||
| Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset | Q73292550 | ||
| High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors | Q77406810 | ||
| Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques | Q77756578 | ||
| Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years | Q78794833 | ||
| Reanalysis of the final results of the European Carotid Surgery Trial | Q78946904 | ||
| Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study | Q79850163 | ||
| Mortality in patients with rheumatoid arthritis treated with low-dose oral glucocorticoids. A population-based cohort study | Q80038470 | ||
| Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy | Q80213278 | ||
| Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis | Q80969856 | ||
| A single nucleotide polymorphism in the IRF5 promoter region is associated with susceptibility to rheumatoid arthritis in the Japanese population | Q81071154 | ||
| Interaction between smoking and polymorphism in the promoter region of the VEGFA gene is associated with ischemic heart disease and myocardial infarction in rheumatoid arthritis | Q83506210 | ||
| Effects of a 6-month infliximab treatment on plasma levels of leptin and adiponectin in patients with rheumatoid arthritis | Q84140105 | ||
| Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis | Q87248594 | ||
| Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis | Q27001736 | ||
| Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: effects of aspirin treatment | Q28175505 | ||
| Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci | Q28281906 | ||
| MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction | Q28581447 | ||
| Inflammation, atherosclerosis, and coronary artery disease | Q29547232 | ||
| Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein | Q29547752 | ||
| Cardiovascular risk factors have larger impact on endothelial function in self-reported healthy women than men in the HUNT3 Fitness study | Q31171909 | ||
| EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis | Q33505914 | ||
| Assessment and treatment of endothelial dysfunction in humans | Q33731648 | ||
| Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis | Q33970887 | ||
| Association of a rheumatoid arthritis susceptibility variant at the CCL21 locus with premature mortality in inflammatory polyarthritis patients | Q34113334 | ||
| Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis | Q34222528 | ||
| Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics | Q34233328 | ||
| The mortality of rheumatoid arthritis | Q34338843 | ||
| Changes in disease characteristics and response rates among patients in the United Kingdom starting anti-tumour necrosis factor therapy for rheumatoid arthritis between 2001 and 2008. | Q34395306 | ||
| Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis | Q34401259 | ||
| Association of DRB1 shared epitope genotypes with early mortality in rheumatoid arthritis: results of eighteen years of followup from the early rheumatoid arthritis study | Q34624148 | ||
| Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab | Q34658023 | ||
| Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease | Q34684331 | ||
| No evidence of association between anti-tumor necrosis factor treatment and mortality in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register | Q34699641 | ||
| Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled study | Q34897630 | ||
| Genome-wide linkage analysis of cardiovascular disease biomarkers in a large, multigenerational family | Q34927051 | ||
| The risk of metabolic syndrome in patients with rheumatoid arthritis: a meta-analysis of observational studies | Q35036116 | ||
| Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease | Q35377706 | ||
| Longitudinal predictors of progression of carotid atherosclerosis in rheumatoid arthritis | Q35489690 | ||
| Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s | Q35554980 | ||
| Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis | Q35638369 | ||
| Patterns of cardiovascular risk in rheumatoid arthritis | Q35638493 | ||
| Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study | Q35676964 | ||
| Seropositivity is associated with insulin resistance in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register (NOAR): an observational study | Q35840769 | ||
| Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies | Q35863952 | ||
| The autoantibody rheumatoid factor may be an independent risk factor for ischaemic heart disease in men | Q36025658 | ||
| Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. | Q36031031 | ||
| Genetic markers of cardiovascular disease in rheumatoid arthritis. | Q36165202 | ||
| Sustained acceleration in carotid atherosclerotic plaque progression with intraplaque hemorrhage: a long-term time course study. | Q36174136 | ||
| Inflammation in atherosclerosis | Q36174933 | ||
| Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis. | Q36190844 | ||
| Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk of rheumatoid arthritis | Q36306362 | ||
| Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation | Q36465464 | ||
| Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis. | Q36633289 | ||
| The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia | Q36791429 | ||
| Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial. | Q36901936 | ||
| Systematic functional regulatory assessment of disease-associated variants. | Q36915402 | ||
| The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis | Q36984506 | ||
| Pathway analysis of seven common diseases assessed by genome-wide association | Q37014849 | ||
| Recent advances in the genetics of RA susceptibility | Q37080741 | ||
| Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients | Q37130018 | ||
| Hypertension in rheumatoid arthritis. | Q37158219 | ||
| The influence of age at symptom onset and length of followup on mortality in patients with recent-onset inflammatory polyarthritis | Q37173846 | ||
| Impact of statin use on lipid levels in statin-naive patients with rheumatoid arthritis versus non-rheumatoid arthritis subjects: results from a population-based study | Q37209902 | ||
| A comparison of vascular inflammation in psoriasis, rheumatoid arthritis, and healthy subjects by FDG-PET/CT: a pilot study | Q37285410 | ||
| Using lifestyle factors to identify individuals at higher risk of inflammatory polyarthritis (results from the European Prospective Investigation of Cancer-Norfolk and the Norfolk Arthritis Register--the EPIC-2-NOAR Study). | Q37465493 | ||
| Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis | Q37466366 | ||
| Brief report: rheumatoid arthritis is associated with left ventricular concentric remodeling: results of a population-based cross-sectional study. | Q37555936 | ||
| Genetic susceptibility to rheumatoid arthritis: an emerging picture | Q37605649 | ||
| The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review | Q37640953 | ||
| Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis | Q37790040 | ||
| Systematic review and meta‐analysis: Anti–tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis | Q37801353 | ||
| Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review | Q37808889 | ||
| Vascular function and morphology in rheumatoid arthritis: a systematic review | Q37934239 | ||
| Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis | Q37998219 | ||
| Genes and coronary artery disease: where are we? | Q38049802 | ||
| Inflammation and immune system interactions in atherosclerosis | Q38083555 | ||
| Pathophysiology of atherosclerosis plaque progression | Q38094421 | ||
| Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm | Q38115132 | ||
| Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3). | Q38199288 | ||
| Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease | Q39378053 | ||
| 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease | Q39946694 | ||
| Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging. | Q40373416 | ||
| Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis | Q41951968 | ||
| Quantifying the exact role of HLA-DRB1 alleles in susceptibility to inflammatory polyarthritis: results from a large, population-based study | Q42599672 | ||
| Impact of shared epitope genotype and ethnicity on erosive disease: a meta-analysis of 3,240 rheumatoid arthritis patients | Q42619505 | ||
| Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk? | Q43255462 | ||
| Does cigarette smoking influence disease expression, activity and severity in early rheumatoid arthritis patients? | Q43498881 | ||
| Body composition phenotypes in systemic lupus erythematosus and rheumatoid arthritis: a comparative study of Caucasian female patients. | Q43667787 | ||
| Antibodies to citrullinated peptides and risk of coronary heart disease | Q43934505 | ||
| HLA-DRB1 genotype associations in 793 white patients from a rheumatoid arthritis inception cohort: frequency, severity, and treatment bias | Q44159740 | ||
| Joint swelling as a predictor of death from cardiovascular disease in a population study of Pima Indians | Q44170460 | ||
| Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease | Q44204800 | ||
| Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events | Q44216708 | ||
| Intra-arterial tumor necrosis factor-alpha impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans. | Q44401148 | ||
| Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis | Q44652560 | ||
| Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? | Q45235877 | ||
| Adiponectin and leptin serum concentrations in patients with rheumatoid arthritis. | Q45929857 | ||
| Insulin resistance and impaired beta cell function in rheumatoid arthritis | Q46161578 | ||
| Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis | Q46222728 | ||
| Carotid plaque characteristics and disease activity in rheumatoid arthritis | Q46487876 | ||
| Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study | Q48559037 | ||
| Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis. | Q51126183 | ||
| Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis. | Q51429519 | ||
| Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysis from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial | Q51652663 | ||
| Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis. | Q51761535 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| atherosclerosis | Q12252367 | ||
| rheumatoid arthritis | Q187255 | ||
| P304 | page(s) | 390-400 | |
| P577 | publication date | 2015-03-31 | |
| P1433 | published in | Nature Reviews Rheumatology | Q2107227 |
| P1476 | title | Atherosclerosis in rheumatoid arthritis: is it all about inflammation? | |
| P478 | volume | 11 |
| Q36182763 | Alterations in skin microvascular function in patients with rheumatoid arthritis and ankylosing spondylitis |
| Q53195970 | Anti-TNFα agents curb platelet activation in patients with rheumatoid arthritis. |
| Q47602822 | Artery compliance in patients with rheumatoid arthritis: results from a case-control study |
| Q38846131 | Association between baseline vitamin D metabolite levels and long-term cardiovascular events in patients with rheumatoid arthritis from the CIMESTRA trial: protocol for a cohort study with patient-record evaluated outcomes |
| Q47628090 | Association between leptin and IL-6 concentrations with cardiovascular risk in patients with rheumatoid arthritis |
| Q52632609 | Asymmetric Dimethyl Arginine as a Biomarker of Atherosclerosis in Rheumatoid Arthritis. |
| Q55017861 | Atherosclerosis and Autoimmunity. |
| Q55413719 | Baicalin reduces blood lipids and inflammation in patients with coronary artery disease and rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. |
| Q91776881 | Cardiometabolic comorbidities in RA and PsA: lessons learned and future directions |
| Q92464675 | Cardiovascular co-morbidity in patients with rheumatoid arthritis: a narrative review of risk factors, cardiovascular risk assessment and treatment |
| Q38813397 | Cardiovascular risk in patients with rheumatoid arthritis |
| Q26744334 | Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps |
| Q52772414 | Cholesterol Accumulation in Dendritic Cells Links the Inflammasome to Acquired Immunity. |
| Q89885688 | Conceptualization of Heterogeneity of Chronic Diseases and Atherosclerosis as a Pathway to Precision Medicine: Endophenotype, Endotype, and Residual Cardiovascular Risk |
| Q52573372 | Cysteine protease cathepsins in cardiovascular disease: from basic research to clinical trials. |
| Q89113492 | Defective cholesterol metabolism in haematopoietic stem cells promotes monocyte-driven atherosclerosis in rheumatoid arthritis |
| Q58715724 | Differential expression of vitamin D associated genes in the aorta of coronary artery disease patients with and without rheumatoid arthritis |
| Q49282700 | Effects of a 12-week cardiovascular rehabilitation programme on systemic inflammation and traditional coronary artery disease risk factors in patients with rheumatoid arthritis (CARDIA trial): a randomised controlled trial |
| Q50085156 | Endothelium-derived contraction in a model of rheumatoid arthritis is mediated via angiotensin II type 1 receptors |
| Q39223803 | Gold nanoparticles in cardiovascular imaging |
| Q26774658 | High-Risk Cardiovascular Patients: Clinical Features, Comorbidities, and Interconnecting Mechanisms |
| Q33678290 | Imaging atherosclerosis in rheumatoid arthritis: evidence for increased prevalence, altered phenotype and a link between systemic and localised plaque inflammation. |
| Q37156561 | Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis |
| Q90415124 | Important Considerations for Examining Endothelial Dysfunction in Rheumatoid Arthritis |
| Q36580903 | Increased Long-Term Cardiovascular Risk After Total Hip Arthroplasty: A Nationwide Cohort Study |
| Q92068746 | Individualized Drug Repositioning For Rheumatoid Arthritis Using Weighted Kolmogorov-Smirnov Algorithm |
| Q102142948 | Inhibition of interleukin-1β signalling promotes atherosclerotic lesion remodelling in mice with inflammatory arthritis |
| Q64885097 | Levels of Lipoprotein (a) in patients with coronary artery disease with and without inflammatory rheumatic disease: a cross-sectional study. |
| Q92054246 | Low serum IGF1 is associated with hypertension and predicts early cardiovascular events in women with rheumatoid arthritis |
| Q37632332 | Major involvement of bacterial components in rheumatoid arthritis and its accompanying oxidative stress, systemic inflammation and hypercoagulability |
| Q91672200 | Management of atherosclerotic plaque in left internal mammary artery graft five years after angiographic patency: A case report |
| Q92409499 | Mercury Is Taken Up Selectively by Cells Involved in Joint, Bone, and Connective Tissue Disorders |
| Q101038356 | Modeling early stage atherosclerosis in a primary human vascular microphysiological system |
| Q39138216 | New insights to the mechanisms underlying atherosclerosis in rheumatoid arthritis. |
| Q90258526 | Physical Activity, Immune System, and the Microbiome in Cardiovascular Disease |
| Q59799935 | Potential role of platelets for atherosclerotic events in rheumatoid arthritis |
| Q89719624 | Predicting the Risk of Ischemic Stroke among Patients with Rheumatoid Arthritis Using a Simplified RA-CHADSV Score Based on the CHA2DS2-VASc Score |
| Q41464826 | Prevalence of Asymptomatic Arterial Hypertension and Its Correlation with Inflammatory Activity in Early Rheumatoid Arthritis. |
| Q48124901 | RNA expression profile of calcified bicuspid, tricuspid, and normal human aortic valves by RNA sequencing |
| Q26773002 | Rapid Progression of Coronary Atherosclerosis: A Review |
| Q91802566 | Regulation of Th17 Cytokine-Induced Osteoclastogenesis via SKI306X in Rheumatoid Arthritis |
| Q59135667 | Repurposing existing drugs for cardiovascular risk management: a focus on methotrexate |
| Q55263498 | Retinal Vessel Diameters and Physical Activity in Patients With Mild to Moderate Rheumatic Disease Without Cardiovascular Comorbidities. |
| Q43122483 | Rheumatoid arthritis and coronary atherosclerosis: two cousins engaging in a dangerous liaison |
| Q33874048 | Risk of cardiovascular disease in Chinese patients with rheumatoid arthritis: A cross-sectional study based on hospital medical records in 10 years. |
| Q90432999 | Role of microRNAs in the Development of Cardiovascular Disease in Systemic Autoimmune Disorders |
| Q50243563 | Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response. |
| Q93083351 | Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study |
| Q51515623 | Systemic Inflammation Affects Human Osteocyte-Specific Protein and Cytokine Expression. |
| Q89314644 | Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases |
| Q26776492 | TNF biology, pathogenic mechanisms and emerging therapeutic strategies |
| Q97521704 | Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients |
| Q54402965 | The Multifaceted Uses and Therapeutic Advantages of Nanoparticles for Atherosclerosis Research. |
| Q37085750 | The Roles of Cigarette Smoking and the Lung in the Transitions Between Phases of Preclinical Rheumatoid Arthritis |
| Q36477400 | The beneficial effects of Tai Chi exercise on endothelial function and arterial stiffness in elderly women with rheumatoid arthritis |
| Q39078542 | The effect of rheumatoid arthritis-associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis |
| Q47842717 | The relation between ischemia modified albumin levels and carotid intima media thickness in patients with rheumatoid arthritis |
| Q36923331 | Unexpected arterial wall and cellular inflammation in patients with rheumatoid arthritis in remission using biological therapy: a cross-sectional study. |
| Q47142007 | Vitamin D Status, Disease Activity, and Endothelial Dysfunction in Early Rheumatoid Arthritis Patients |
| Q28074148 | What is the impact of biologic therapies on common co-morbidities in patients with rheumatoid arthritis? |
| Q39374245 | Why location matters - site-specific factors in rheumatic diseases. |
| Q60141621 | measurements of hemodynamic forces and their effects on endothelial cell mechanics at the sub-cellular level |
Search more.